| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |